Subscribe To
Why veru stock is surging today
Veru Inc (NASDAQ: VERU) shares are trading significantly higher Monday after the company reported its novel COVID-19 drug candidate reduced deaths by...
April 11, 2022, 10:50 am
Pharma stock surging on upbeat covid-19 treatment data
Another company could be joining the ranks of Covid-19 treatment producers: Veru Inc (NASDAQ:VERU)....
April 11, 2022, 9:27 am
Adverum (advm) up on fda feedback for gene therapy study
Adverum (ADVM) to submit IND amendment to the FDA by mid-2022 for starting a mid-stage study on its gene therapy candidate ADVM-022 for treating wet A...
April 7, 2022, 4:34 pm
Adverum moves forward with ind amendment for advm-022 phase 2 trial in wet amd
Adverum Biotechnologies Inc (NASDAQ: ADVM) received feedback via a Type C meeting written response from the FDA regarding its planned Phase 2 trial...
April 7, 2022, 7:43 am
Two major stocks with strong fundamentals offering a solid set up
Buy low and sell high – an overused adage on Wall Street but one that made patient investors rich. Getting....
April 1, 2022, 7:33 am
Veru inc. (veru) ceo mitchell steiner on q1 2022 results - earnings call transcript
Veru Inc. (VERU) CEO Mitchell Steiner on Q1 2022 Results - Earnings Call Transcript...
February 9, 2022, 2:26 pm
Veru inc. (veru) ceo mitchell steiner on q1 2022 results - earnings call transcript
Veru Inc. (VERU) CEO Mitchell Steiner on Q1 2022 Results - Earnings Call Transcript...
February 9, 2022, 2:26 pm
Veru inc. (veru) ceo mitchell steiner on q1 2022 results - earnings call transcript
Veru Inc. (VERU) CEO Mitchell Steiner on Q1 2022 Results - Earnings Call Transcript...
February 9, 2022, 2:26 pm
Veru inc. (veru) reports q1 loss, misses revenue estimates
Veru Inc. (VERU) delivered earnings and revenue surprises of 27.27% and 17.99%, respectively, for the quarter ended December 2021. Do the numbers hold...
February 9, 2022, 9:13 am
Veru inc. (veru) reports q1 loss, misses revenue estimates
Veru Inc. (VERU) delivered earnings and revenue surprises of 27.27% and 17.99%, respectively, for the quarter ended December 2021. Do the numbers hold...
February 9, 2022, 9:13 am
Veru inc. (veru) reports q1 loss, misses revenue estimates
Veru Inc. (VERU) delivered earnings and revenue surprises of 27.27% and 17.99%, respectively, for the quarter ended December 2021. Do the numbers hold...
February 9, 2022, 9:13 am
Can veru inc. (veru) climb 344% to reach the level wall street analysts expect?
The consensus price target hints at a 343.6% upside potential for veru Inc. (VERU). While empirical res...
February 8, 2022, 11:30 am
Can veru inc. (veru) climb 344% to reach the level wall street analysts expect?
The consensus price target hints at a 343.6% upside potential for veru Inc. (VERU). While empirical res...
February 8, 2022, 11:30 am
Can veru inc. (veru) climb 344% to reach the level wall street analysts expect?
The consensus price target hints at a 343.6% upside potential for veru Inc. (VERU). While empirical res...
February 8, 2022, 11:30 am
Oil boom 2022: u.s. oil price tops $90 for first time since 2014
The price for a barrel of West Texas Intermediate topped the $90 mark for the first time since 2014 Thursday, as the Enverus domestic rig count rose t...
February 3, 2022, 3:12 pm
Oil boom 2022: u.s. oil price tops $90 for first time since 2014
The price for a barrel of West Texas Intermediate topped the $90 mark for the first time since 2014 Thursday, as the Enverus domestic rig count rose t...
February 3, 2022, 3:12 pm
Oil boom 2022: u.s. oil price tops $90 for first time since 2014
The price for a barrel of West Texas Intermediate topped the $90 mark for the first time since 2014 Thursday, as the Enverus domestic rig count rose t...
February 3, 2022, 3:12 pm
Veru's cancer candidate sabizabulin gets fda fast track tag for covid-19
The FDA has granted Fast Track designation to Veru Inc's VERU sabizabulin, oral cytoskeleton disruptor, to combat COVID-19 infection and the cytok...
January 31, 2022, 11:41 am
Veru's cancer candidate sabizabulin gets fda fast track tag for covid-19
The FDA has granted Fast Track designation to Veru Inc's VERU sabizabulin, oral cytoskeleton disruptor, to combat COVID-19 infection and the cytok...
January 31, 2022, 11:41 am
Veru's cancer candidate sabizabulin gets fda fast track tag for covid-19
The FDA has granted Fast Track designation to Veru Inc's VERU sabizabulin, oral cytoskeleton disruptor, to combat COVID-19 infection and the cytok...
January 31, 2022, 11:41 am